The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Screening for prostate cancer
Open accessAbstract
BACKGROUND: Any form of screening aims to reduce disease-specific and overall mortality, and to improve a person's future quality of life. Screening for prostate cancer has generated considerable debate within the medical and broader community, as demonstrated by the varying recommendations made by medical organizations and governed by national policies. To better inform individual patient decision-making and health policy decisions, we need to consider the entire body of data from randomised controlled trials (RCTs) on prostate cancer screening summarised in a systematic review. In 2006, our Cochrane review identified insufficient evidence to either support or refute the use of routine mass, selective, or opportunistic screening for prostate cancer. An update of the review in 2010 included three additional trials. Meta-analysis of the five studies included in the 2010 review concluded that screening did not significantly reduce prostate cancer-specific mortality. In the past two years, several updates to studies included in the 2010 review have been published thereby providing the rationale for this update of the 2010 systematic review. OBJECTIVES: To determine whether screening for prostate cancer reduces prostate cancer-specific mortality or all-cause mortality and to assess its impact on quality of life and adverse events. SEARCH METHODS: An updated search of electronic databases (PROSTATE register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CANCERLIT, and the NHS EED) was performed, in addition to handsearching of specific journals and bibliographies, in an effort to identify both published and unpublished trials. SELECTION CRITERIA: All RCTs of screening versus no screening for prostate cancer were eligible for inclusion in this review. DATA COLLECTION AND ANALYSIS: The original search (2006) identified 99 potentially relevant articles that were selected for full-text review. From these citations, two RCTs were identified as meeting the inclusion criteria. The search for the 2010 version of the review identified a further 106 potentially relevant articles, from which three new RCTs were included in the review. A total of 31 articles were retrieved for full-text examination based on the updated search in 2012. Updated data on three studies were included in this review. Data from the trials were independently extracted by two authors. MAIN RESULTS: Five RCTs with a total of 341,342 participants were included in this review. All involved prostate-specific antigen (PSA) testing, with or without digital rectal examination (DRE), though the interval and threshold for further evaluation varied across trials. The age of participants ranged from 45 to 80 years and duration of follow-up from 7 to 20 years. Our meta-analysis of the five included studies indicated no statistically significant difference in prostate cancer-specific mortality between men randomised to the screening and control groups (risk ratio (RR) 1.00, 95% confidence interval (CI) 0.86 to 1.17). The methodological quality of three of the studies was assessed as posing a high risk of bias. The European Randomized Study of Screening for Prostate Cancer (ERSPC) and the US Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial were assessed as posing a low risk of bias, but provided contradicting results. The ERSPC study reported a significant reduction in prostate cancer-specific mortality (RR 0.84, 95% CI 0.73 to 0.95), whilst the PLCO study concluded no significant benefit (RR 1.15, 95% CI 0.86 to 1.54). The ERSPC was the only study of the five included in this review that reported a significant reduction in prostate cancer-specific mortality, in a pre-specified subgroup of men aged 55 to 69 years of age. Sensitivity analysis for overall risk of bias indicated no significant difference in prostate cancer-specific mortality when referring to the meta analysis of only the ERSPC and PLCO trial data (RR 0.96, 95% CI 0.70 to 1.30). Subgroup analyses indicated that prostate cancer-specific mortality was not affected by the age at which participants were screened. Meta-analysis of four studies investigating all-cause mortality did not determine any significant differences between men randomised to screening or control (RR 1.00, 95% CI 0.96 to 1.03). A diagnosis of prostate cancer was significantly greater in men randomised to screening compared to those randomised to control (RR 1.30, 95% CI 1.02 to 1.65). Localised prostate cancer was more commonly diagnosed in men randomised to screening (RR 1.79, 95% CI 1.19 to 2.70), whilst the proportion of men diagnosed with advanced prostate cancer was significantly lower in the screening group compared to the men serving as controls (RR 0.80, 95% CI 0.73 to 0.87). Screening resulted in a range of harms that can be considered minor to major in severity and duration. Common minor harms from screening include bleeding, bruising and short-term anxiety. Common major
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Lewis, K., Barry, M. J., Bennett, C. L., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub5 · Cited by 6,685
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Cochrane Handbook for Systematic Reviews of Interventions
Tarsilla, M. (2010) · Journal of MultiDisciplinary Evaluation · doi:10.56645/jmde.v6i14.284 · Cited by 5,178
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
The Development of Human Benign Prostatic Hyperplasia with Age
Berry, S. J., Coffey, D. S., Walsh, P. C., & Ewing, L. L. (1984) · Journal of Urology · doi:10.1016/s0022-5347(17)49698-4 · Cited by 2,488
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Wilt, T. J., Brawer, M. K., Jones, K. M., Barry, M. J., Aronson, W. J., Fox, S., Gingrich, J. R., Wei, J. T., Gilhooly, P., Grob, B. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113162 · Cited by 1,770
Heidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Mason, M., Matveev, V., Mottet, N., Schmid, H.-P., van der Kwast, T., Wiegel, T., et al. (2011) · European Urology · doi:10.1016/j.eururo.2010.10.039 · Cited by 1,492
Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35410-1 · Cited by 1,278
Prostate-Cancer Mortality at 11 Years of Follow-up
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113135 · Cited by 1,245
Grönberg, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12713-4 · Cited by 1,219
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Isaacs, C., Kvale, P. A., Reding, D. J., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr500 · Cited by 1,121
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043739 · Cited by 1,111
Draisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A. M., Schroder, F. H., & de Koning, H. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.868 · Cited by 1,071
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
Prorok, P. C., Andriole, G. L., Bresalier, R. S., Buys, S. S., Chia, D., David Crawford, E., Fogel, R., Gelmann, E. P., Gilbert, F., Hasson, M. A., et al. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00098-2 · Cited by 1,037
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20066 · Cited by 965
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
Hugosson, J., Carlsson, S., Aus, G., Bergdahl, S., Khatami, A., Lodding, P., Pihl, C.-G., Stranne, J., Holmberg, E., & Lilja, H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70146-7 · Cited by 936
Chapter 12: Interpreting results and drawing conclusions
Schünemann, H. J., Oxman, A. D., Jonathan, J., & Glasziou, P. (2011) · Cited by 870
前立腺癌のEAUガイドライン。パート1:臨床的限局性疾患のスクリーニング,診断および治療
Heidenreich, A., Bellmunt, J., Bolla, M., et al. (2011) · European Urology · Cited by 866
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Decision aids for people facing health treatment or screening decisions
O'Connor, A. M., Bennett, C. L., Stacey, D., Barry, M., Col, N. F., Eden, K. B., Entwistle, V. A., Fiset, V., Holmes-Rovner, M., Khangura, S., et al. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub2 · Cited by 693
Bill-Axelson, A., Holmberg, L., Filen, F., Ruutu, M., Garmo, H., Busch, C., Nordling, S., Haggman, M., Andersson, S.-O., Bratell, S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn255 · Cited by 603
Wilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00209 · Cited by 597
Gohagan, J. K., Prorok, P. C., Hayes, R. B., & Kramer, B.-S. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00097-0 · Cited by 544
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 505
Accuracy of Self-Reported Cancer-Screening Histories: A Meta-analysis
Rauscher, G. H., Johnson, T. P., Cho, Y. I., & Walk, J. A. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2629 · Cited by 487
Investigating and Dealing with Publication and Other Biases
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch11 · Cited by 449
Outcomes of Localized Prostate Cancer Following Conservative Management
Lu-Yao, G. L. (2009) · JAMA · doi:10.1001/jama.2009.1348 · Cited by 430
Quality-of-Life Effects of Prostate-Specific Antigen Screening
Heijnsdijk, E. A. M., Wever, E. M., Auvinen, A., Hugosson, J., Ciatto, S., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201637 · Cited by 427
Serum Prostate Specific Antigen as Pre-Screening Test for Prostate Cancer
Labrie, F., Dupont, A., Suburu, R., Cusan, L., Tremblay, M., Gomez, J.-L., & Emond, J. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37402-5 · Cited by 337
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials
Djulbegovic, M., Beyth, R. J., Neuberger, M. M., Stoffs, T. L., Vieweg, J., Djulbegovic, B., & Dahm, P. (2010) · BMJ · doi:10.1136/bmj.c4543 · Cited by 337
Self-citationBartsch, G., Horninger, W., Klocker, H., Reissigl, A., Oberaigner, W., Schönitzer, D., Severi, G., Robertson, C., & Boyle, P. (2001) · Urology · doi:10.1016/s0090-4295(01)01264-x · Cited by 315
Lin, K., Lipsitz, R., Miller, T., & Janakiraman, S. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00009 · Cited by 310
Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram
Steyerberg, E. W., Roobol, M. J., Kattan, M. W., van der Kwast, T. H., de Koning, H. J., & Schröder, F. H. (2007) · Journal of Urology · doi:10.1016/j.juro.2006.08.068 · Cited by 304
Rosario, D. J., Lane, J. A., Metcalfe, C., Donovan, J., Doble, A., Goodwin, L., Davis, M., Catto, J. W. F., AVERY, K. N. L., Neal, D. E., et al. (2012) · BMJ · doi:10.1136/bmj.d7894 · Cited by 294
de Koning, H. J., Auvinen, A., Berenguer Sanchez, A., Calais da Silva, F., Ciatto, S., Denis, L., Gohagan, J. K., Hakama, M., Hugosson, J., Kranse, R., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.1588 · Cited by 285
Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study
Collin, S. M., Martin, R. M., Metcalfe, C., Gunnell, D., Albertsen, P. C., Neal, D., Hamdy, F., Stephens, P., Lane, J. A., Moore, R., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70104-9 · Cited by 272
Age and Racial Distribution of Prostatic Intraepithelial Neoplasia
Sakr, W., Grignon, D. J., Haas, G. P., Heilbrun, L. K., Pontes, J. E., & Crissmana, J. D. (1996) · European Urology · doi:10.1159/000474163 · Cited by 258
Vickers, A. J., Cronin, A. M., Aus, G., Pihl, C.-G., Becker, C., Pettersson, K., Scardino, P. T., Hugosson, J., & Lilja, H. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-19 · Cited by 249
Labrie, F., Candas, B., Cusan, L., Gomez, J. L., Bélanger, A., Brousseau, G., Chevrette, E., & Lévesque, J. (2004) · The Prostate · doi:10.1002/pros.20017 · Cited by 227
Janes, H., & Pepe, M. S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn099 · Cited by 212
Gohagan, J. K., Prorok, P. C., Kramer, B. S., & Cornett, J. E. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32412-6 · Cited by 210
Rietbergen, J. B. W., Kruger, A. E. B., Kranse, R., & Schröder, F. H. (1997) · Urology · doi:10.1016/s0090-4295(97)00100-3 · Cited by 200
Essink-Bot, M.-L., de Koning, H. J., Nijs, H. G. T., Kirkels, W. J., van der Maas, P. J., & Schroder, F. H. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.925 · Cited by 174
de Koning, H. J., Liem, M. K., Baan, C. A., Boer, R., Schröder, F. H., & Alexander on behalf of ERSPC, F. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10188 · Cited by 170
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
Heijnsdijk, E. A. M., der Kinderen, A., Wever, E. M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605422 · Cited by 165
Roemeling, S., Roobol, M. J., de Vries, S. H., Wolters, T., Gosselaar, C., van Leenders, G. J. L. H., & Schröder, F. H. (2007) · European Urology · doi:10.1016/j.eururo.2006.11.053 · Cited by 160
Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial
Crawford, E. D., Grubb, R., Black, A., Andriole, G. L., Chen, M.-H., Izmirlian, G., Berg, C. D., & D'Amico, A. V. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5979 · Cited by 159
Ali, K., Gunnar, A., Jan‐Erik, D., Lilja, H. G., Pär, L., & Jonas, H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22161 · Cited by 157
Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
Croswell, J. M., Kramer, B. S., Kreimer, A. R., Prorok, P. C., Xu, J.-L., Baker, S. G., Fagerstrom, R. M., Riley, T. L., Clapp, J. D., Berg, C. D., et al. (2009) · The Annals of Family Medicine · doi:10.1370/afm.942 · Cited by 153
Lane, J. A., Hamdy, F. C., Martin, R. M., Turner, E. L., Neal, D. E., & Donovan, J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.016 · Cited by 149
Pinsky, P. F., Black, A., Kramer, B. S., Miller, A. B., Prorok, P. C., & Berg, C. D. (2010) · Clinical Trials · doi:10.1177/1740774510374091 · Cited by 145
Prostate specific antigen for early detection of prostate cancer: longitudinal study
Holmström, B., Johansson, M., Bergh, A. R. J., Stenman, U., Hallmans, G., & Stattin, P. (2009) · BMJ · doi:10.1136/bmj.b3537 · Cited by 135
Grubb, R. L., Black, A., Izmirlian, G., Hickey, T. P., Pinsky, P. F., Mabie, J. E., Riley, T. L., Ragard, L. R., Prorok, P. C., Berg, C. D., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0938 · Cited by 130
Patient Education on Prostate Cancer Screening and Involvement in Decision Making
Krist, A. H., Woolf, S. H., Johnson, R. E., & Kerns, J. W. (2007) · The Annals of Family Medicine · doi:10.1370/afm.623 · Cited by 129
Screening for Prostate Cancer in U.S. Men
Lim, L. S., & Sherin, K. M. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.10.003 · Cited by 126
Kramer, B. S., Hagerty, K. L., Justman, S., Somerfield, M. R., Albertsen, P. C., Blot, W. J., Carter, H. B., Costantino, J. P., Epstein, J. I., Godley, P. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9599 · Cited by 123
Ilić, D., O’Connor, D. A., Green, S., & Wilt, T. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004720.pub2 · Cited by 108
D'Amico, A. V., & Roehrborn, C. G. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70981-0 · Cited by 107
Johansson, E., Bill‐Axelson, A., Holmberg, L., Onelöv, E., Johansson, J., & Steineck, G. (2008) · European Urology · doi:10.1016/j.eururo.2008.08.054 · Cited by 104
Finasteride Improves the Sensitivity of Digital Rectal Examination for Prostate Cancer Detection
Thompson, I. M., Tangen, C. M., Goodman, P. J., Lucia, M. S., Parnes, H. L., Lippman, S. M., & Coltman, C. A. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.071 · Cited by 103
for the Prostate, L., Leitzmann, M. F., Ahn, J., Albanes, D., Hsing, A. W., Schatzkin, A. G., Chang, S.-C., Huang, W., Weiss, J. M., Danforth, K. N., et al. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9198-6 · Cited by 97
A Prospective Study ofTrans-Fatty Acid Levels in Blood and Risk of Prostate Cancer
Chavarro, J. E., Stampfer, M. J., Campos, H., Kurth, T., Willett, W. C., & Ma, J. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0673 · Cited by 93
Beemsterboer, P. M. M., Ries Kranse, C., de Koning, H. J., Habbema, J. D. F., & Schr�der, F. H. (1999) · International Journal of Cancer · Cited by 92
False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up
Wolters, T., van der Kwast, T., Vissers, C. J., Bangma, C. H., Roobol, M. J., Schröder, F. H., & van Leenders, G. J. L. H. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181c3ece9 · Cited by 88
Frosch, D. L., Bhatnagar, V., Tally, S., Hamori, C. J., & Kaplan, R. M. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.111 · Cited by 86
Online spaced education to teach urology to medical students: a multi-institutional randomized trial
Kerfoot, B. P., & Brotschi, E. A. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.10.026 · Cited by 79
Pashayan, N., Duffy, S. W., Pharoah, P. D. P., Greenberg, D., Donovan, J., Martin, R. M., Hamdy, F. C., & Neal, D. E. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604973 · Cited by 76
Labrie, F., Candas, B., Cusan, L., Gomez, J., Diamond, P., Suburu, R. E., & Lemay, M. (1996) · Urology · doi:10.1016/s0090-4295(99)80419-1 · Cited by 76
Endogenous sex hormones and the risk of prostate cancer: A prospective study
Weiss, J. M., Huang, W., Rinaldi, S., Fears, T. R., Chatterjee, N., Hsing, A. W., Crawford, E. D., Andriole, G. L., Kaaks, R., & Hayes, R. B. (2008) · International Journal of Cancer · doi:10.1002/ijc.23326 · Cited by 74
Carlsson, S., Aus, G., Wessman, C., & Hugosson, J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.06.002 · Cited by 73
A Randomized Trial of Lycopene Supplementation in Tobago Men with High Prostate Cancer Risk
Bunker, C. H., McDonald, A. C., Evans, R. W., de la Rosa, N., Boumosleh, J. M., & Patrick, A. L. (2007) · Nutrition and Cancer · doi:10.1080/01635580701274046 · Cited by 72
Nomogram use for the prediction of indolent prostate cancer
Roemeling, S., Roobol, M. J., Kattan, M. W., van der Kwast, T., Steyerberg, E. W., & Schröder, F. H. (2007) · Cancer · doi:10.1002/cncr.23029 · Cited by 71
Raaijmakers, R., BLIJENBERG, B. G., Finlay, J. A., et al. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000127731.56103.50 · Cited by 71
Active surveillance for prostate cancer: trials and tribulations
Klotz, L. H. (2008) · World Journal of Urology · doi:10.1007/s00345-008-0330-8 · Cited by 69
Use of Biomarkers in Screening for Cancer
Duffy, M. J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-7215-0_3 · Cited by 69
Fleshner, N. E., Gomella, L. G., Cookson, M. S., Finelli, A., Evans, A., Taneja, S. S., Lucia, M. S., Wolford, E. T., Somerville, M. C., & Rittmaster, R. S. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2007.05.006 · Cited by 68
Kramer, B. S., Hagerty, K. L., Justman, S., Somerfield, M. R., Albertsen, P. C., Blot, W. J., Carter, H. B., Costantino, J. P., Epstein, J. I., Godley, P. A., et al. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.01.071 · Cited by 67
Mortality and prostate cancer risk in 19 598 men after surgery for benign prostatic hyperplasia
Holman, Wisniewski, Semmens, Rouse, & Bass (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00123.x · Cited by 66
The Committee for Establishment of the Guidelines on Screening for Prostate Cancer, & Japanese Urological Association (2010) · International Journal of Urology · doi:10.1111/j.1442-2042.2010.02613.x · Cited by 65
van Leeuwen, P. J., Connolly, D., Gavin, A., Roobol, M. J., Black, A., Bangma, C. H., & Schröder, F. H. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.09.008 · Cited by 63
Jacobsen, S. J., Bergstralh, E. J., Katusic, S. K., Guess, H. A., Darby, C. H., Silverstein, M. D., Oesterling, J. E., & Lieber, M. M. (1998) · Urology · doi:10.1016/s0090-4295(98)00171-x · Cited by 62
Should We Replace the Gleason Score with the Amount of High-Grade Prostate Cancer?
Vis, A. N., Roemeling, S., Ries Kranse, C., Schröder, F. H., & van der Kwast, T. (2006) · European Urology · doi:10.1016/j.eururo.2006.07.051 · Cited by 57
Family History and Prostate Cancer Screening With Prostate-Specific Antigen
Mäkinen, T., Tammela, T. L. J., Stenman, U., Määttänen, L., Rannikko, S., Aro, J. L. V., Juusela, H., Hakama, M., & Auvinen, A. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.006 · Cited by 48
Wallner, L. P., Sarma, A. V., Lieber, M. M., Sauver, J. L. S., Jacobson, D. J., McGree, M. E., Gowan, M. E., & Jacobsen, S. J. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0050 · Cited by 48
The value of an additional hypoechoic lesion‐directed biopsy core for detecting prostate cancer
Gosselaar, C., Roobol, M. J., Roemeling, S., Wolters, T., van Leenders, G. J. L. H., & Schröder, F. H. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07309.x · Cited by 46
Low-Literacy Interventions to Promote Discussion of Prostate Cancer
Kripalani, S. B., Sharma, J., Justice, E., Justice, J. M., Spiker, C. A., Laufman, L. E., Price, M., & Weinberg, A. D. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.03.018 · Cited by 45
Zackrisson, B. (2003) · European Urology · doi:10.1016/s0302-2838(03)00044-7 · Cited by 40
The Japanese Guideline for Prostate Cancer Screening
Hamashima, C., Nakayama, T., Sagawa, M., Saito, H., & Sobue, T. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp025 · Cited by 40
Carlsson, S., Aus, G., Bergdahl, S., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.016 · Cited by 39
Recruiting Older African American Men to a Cancer Screening Trial (The AAMEN Project)
Ford, M. E., Havstad, S. L., & Tilley, B. C. (2003) · The Gerontologist · doi:10.1093/geront/43.1.27 · Cited by 39
Kawamura, K., Suzuki, H., Kamiya, N., Imamoto, T., Yano, M., Miura, J., Shimbo, M., Suzuki, N., Nakatsu, H., & Ichikawa, T. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02058.x · Cited by 38
Auvinen, A. P., Tammela, T. L. J., Stenman, U.-H., Uusi-Erkkilä, I., Leinonen, J., Schröder, F., & Hakama, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.402 · Cited by 36
Kerfoot, B. P. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.01.126 · Cited by 36
Ellison, G. L., Weinrich, S., Lou, M., Xu, H., Powell, I. J., & Baquet, C. R. (2008) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)31481-4 · Cited by 34
Rietbergen, J., Ries Kranse, C., Hoedemaeker, R. F., Kruger, A. E. B., Bangma, C. H., Kirkels, W. J., & Schröder, F. H. (1998) · Urology · doi:10.1016/s0090-4295(98)00138-1 · Cited by 34
Khatami, A., Hugosson, J., Wang, W., & Damber, J. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590802469543 · Cited by 32
Promoting Prostate-Specific Antigen Informed Decision-Making
Driscoll, D., Rupert, D. J., Golin, C. E., Mccormack, L. A., Sheridan, S., Welch, B. M., & Poehlman, J. A. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.04.016 · Cited by 31
Continuity of Care and Cancer Screening Among Health Plan Enrollees
Fenton, J. J., Franks, P. J., Reid, R. J., Elmore, J. G., & Baldwin, L. (2008) · Medical Care · doi:10.1097/mlr.0b013e318148493a · Cited by 31
Risk of Developing Prostate Cancer in the Future: Overview of Prognostic Biomarkers
Fleshner, N. E., & Lawrentschuk, N. (2009) · Urology · doi:10.1016/j.urology.2009.02.022 · Cited by 31
Population-Based Case-Control Study of PSA and DRE Screening on Prostate Cancer Mortality
Bergstralh, E. J., Roberts, R. O., Farmer, S. A., Slezak, J. M., Lieber, M. M., & Jacobsen, S. J. (2007) · Urology · doi:10.1016/j.urology.2007.07.009 · Cited by 27
Roemeling, S., Roobol, M. J., Otto, S. J., Habbema, D., Gosselaar, C., Lous, J. J., Cuzick, J. M., & Schröder, F. H. (2007) · The Prostate · doi:10.1002/pros.20606 · Cited by 27
Stephens, R. L., Xu, Y. L., Volk, R. J., Scholl, L. E., Kamin, S. L., Holden, E. W., & Stroud, L. A. (2008) · Health Psychology · doi:10.1037/0278-6133.27.6.711 · Cited by 24
Kjellman, A., Akre, O., Norming, U., Törnblom, M., & Gustafsson, O. (2007) · European Urology · doi:10.1016/j.eururo.2007.04.063 · Cited by 23
Prostatakarzinomfrüherkennung in Deutschland
Sieverding, M., Matterne, U., Ciccarello, L., & Luboldt, H. ‐. (2008) · Der Urologe · doi:10.1007/s00120-008-1695-4 · Cited by 22
Prostate-Specific Antigen Screening and Mortality from Prostate Cancer
Marcella, S. W., Rhoads, G. G., Carson, J. L., Merlino, F., & Wilcox, H. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0479-7 · Cited by 20
de Koning, H. J., Hakulinen, T. R., Moss, S., et al. (2003) · British Journal of Urology · doi:10.1111/j.1464-410x.2003.4410x.x · Cited by 17
What Will the Emperor Say? Screening for Prostate Cancer as of 2008
Concato, J. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e31819765da · Cited by 12
Treatment of the positive surgical margin following radical prostatectomy
Yang, Y. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200802020-00017 · Cited by 11
Ford, M. E., Havstad, S. L., Fields, M., Manigo, B., McClary, B., & Lamerato, L. E. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0118 · Cited by 11
Labrie, F., Cusan, L., Gomez, J., Levesque, J., & Candas, B. (1999) · The Aging Male · doi:10.3109/13685539909003181 · Cited by 10
Statistical issues in the evaluation of screening and early detection modalities
Etzioni, R. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2006.11.008 · Cited by 8
Prostate Cancer – To screen, or not to screen, is that the question?
Rosser, C. J. (2008) · BMC Urology · doi:10.1186/1471-2490-8-20 · Cited by 8
[Screening for prostate cancer--what does the evidence show?].
Borre, M., & Iversen, P. (2007) · PubMed · Cited by 6
Lin, A., & Small, E. J. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3280ad43bd · Cited by 6
Le cancer de la prostate, le point sur le dépistage
Grosclaude, P. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32741-4 · Cited by 3
Cited by
Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Crosby, D., Bhatia, S., Brindle, K. M., Coussens, L. M., Dive, C., Emberton, M., Esener, S., Fitzgerald, R. C., Gambhir, S. S., Kuhn, P., et al. (2022) · Science · doi:10.1126/science.aay9040 · Cited by 1,379
Prostate-Cancer Mortality at 11 Years of Follow-up
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113135 · Cited by 1,245
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Metadata
- Authors
- Ilic, D., Neuberger, M. M., Djulbegovic, M., & Dahm, P.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-01-31
- Volume
- 2013
- Issue
- 1
- Pages
- CD004720-CD004720
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2144298794
- Cited by
- 1,150
- References
- 123
- FWCI
- 115.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.